K vs VXRT · P/E 23, $29.03B cap vs rev $28.7M
Kellanova (K) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
K does not have a complete income-statement cache yet.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
K currently screens at market cap $29.03B and trailing P/E 22.8. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the K and VXRT stock pages for the full models.
Not investment advice.